Fady M. Kaldas, MD

Fady M. Kaldas, MD

Transplant Surgery
Primary Location
Pfleger Liver Institute
200 Medical Plaza
Los Angeles, California 90095


Academic/Professional Titles

  • Associate Professor of Surgery
  • Kelly Lee Tarantello Chair in Integrative Liver Transplantation
  • Director, Liver Transplant Service
  • Director, Transplant & Hepatobiliary Surgery Fellowship & Program
  • Co-Director, Heart-Liver Disease Program

Dr. Kaldas is a native of southern California where he completed his undergraduate studies in microbiology, immunology, and molecular genetics at UCLA, and obtained his Doctor of Medicine degree at the University of California Irvine School of Medicine. He then moved to New York where he completed his surgical residency training at SUNY Stony Brook Department of Surgery before returning to UCLA to complete his multi-organ transplant fellowship training under the mentorship of Dr. Ronald W. Busuttil at the Dumont-UCLA transplant center. Dr. Kaldas is certified by the American Board of Surgery and the American Society of Transplant Surgeons, and he is a Fellow of the American College of Surgeons. Dr. Kaldas specializes in the surgical management of benign and malignant liver disease. This ranges from laparoscopic and open liver resection for tumors such as liver cancer, bile duct cancer, and metastatic colon cancer to complex liver transplantation. He has active research studies in hepatocellular carcinoma and ischemia reperfusion injury of the liver.


Medical Board Certification

Surgery, American Board of Surgery, 2012


UCLA School of Medicine, 2010


SUNY Stony Brook School of Medicine, 2008


SUNY Stony Brook School of Medicine, 2003


UC Irvine College of Medicine, MD, 2002


West Los Angeles

Pfleger Liver Institute

Liver Transplant Surgery| Hepatobiliary and Pancreatic Surgery| Pediatric Liver Transplant Surgery

Hospital Affiliations

Ronald Reagan UCLA Medical Center


Challenges and Considerations of Combined OHT/OLT - Fady Kaldas, MD | 2019 NFFS Symposium



  1. Outpatient Management of Liver Function Test Abnormalities in Patients With a Liver Transplant.

    Graham DS, Busuttil RW, Kaldas FM.

    JAMA. 2020 Nov 10;324(18):1896-1897. doi: 10.1001/jama.2020.15919.

    PMID: 33170243 No abstract available.

  2. Nonanastomotic Biliary Strictures After Liver Transplantation.

    Ito Md T, Botros Md M, Aziz Bs A, Guorgui Bs JG, Agopian Md VG, Farmer Md DG, Busuttil Md PhD RW, Kaldas FM.

    Am Surg. 2020 Oct 30:3134820964461. doi: 10.1177/0003134820964461. Online ahead of print.

    PMID: 33125271

  3. Cholecystitis in Patients Undergoing Liver Transplantation: A Five-Year Analysis of Incidence, Causes, and Impact.

    Graham DS, Ito T, Lu M, Dinorcia J, Agopian VG, Farmer DG, Busuttil RW, Kaldas FM.

    Am Surg. 2020 Oct 30:3134820964210. doi: 10.1177/0003134820964210. Online ahead of print.

    PMID: 33125269

  4. The Impact of Previous Abdominal Surgery in a High-Acuity Liver Transplant Population.

    Aziz A, Ito T, Younan S, DiNorcia J 3rd, Agopian VG, Farmer DG, Busuttil RW, Kaldas FM.

    J Surg Res. 2020 Oct 24:S0022-4804(20)30627-2. doi: 10.1016/j.jss.2020.08.064. Online ahead of print.

    PMID: 33109401

  5. Ischemia-Reperfusion Injury in Allogeneic Liver Transplantation: A Role of CD4 T Cells in Early Allograft Injury.

    Kageyama S, Kadono K, Hirao H, Nakamura K, Ito T, Gjertson DW, Sosa RA, Reed EF, Kaldas FM, Busuttil RW, Kupiec-Weglinski JW, Zhai Y.

    Transplantation. 2020 Oct 15. doi: 10.1097/TP.0000000000003488. Online ahead of print.

    PMID: 33065722

  6. Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction.

    Agopian VG, Markovic D, Klintmalm GB, Saracino G, Chapman WC, Vachharajani N, Florman SS, Tabrizian P, Haydel B, Nasralla D, Friend PJ, Boteon YL, Ploeg R, Harlander-Locke MP, Xia V, DiNorcia J, Kaldas FM, Yersiz H, Farmer DG, Busuttil RW.

    J Hepatol. 2020 Sep 22:S0168-8278(20)33627-8. doi: 10.1016/j.jhep.2020.09.015. Online ahead of print.

    PMID: 32976864 

  7. Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver-Kidney Transplantation.

    Lunsford KE, Agopian VG, Yi SG, Nguyen DTM, Graviss EA, Harlander-Locke MP, Saharia A, Kaldas FM, Mobley CM, Zarrinpar A, Hobeika MJ, Veale JL, Podder H, Farmer DG, Knight RJ, Danovitch GM, Gritsch HA, Li XC, Ghobrial RM, Busuttil RW, Gaber AO.

    Transplantation. 2020 Aug;104(8):1591-1603. doi: 10.1097/TP.0000000000003040.

    PMID: 32732836 

  8. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients.

    Ito T, Naini BV, Markovic D, Aziz A, Younan S, Lu M, Hirao H, Kadono K, Kojima H, DiNorcia J 3rd, Agopian VG, Yersiz H, Farmer DG, Busuttil RW, Kupiec-Weglinski JW, Kaldas FM.

    Am J Transplant. 2020 Jul 26. doi: 10.1111/ajt.16219. Online ahead of print.

    PMID: 32713098 

  9. Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells.

    Court CM, Hou S, Liu L, Winograd P, DiPardo BJ, Liu SX, Chen PJ, Zhu Y, Smalley M, Zhang R, Sadeghi S, Finn RS, Kaldas FM, Busuttil RW, Zhou XJ, Tseng HR, Tomlinson JS, Graeber TG, Agopian VG.

    NPJ Precis Oncol. 2020 Jul 2;4:16. doi: 10.1038/s41698-020-0123-0. eCollection 2020.

    PMID: 32637655 Free PMC article. 

  10. Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.

    Sosa RA, Terry AQ, Kaldas FM, Jin YP, Rossetti M, Ito T, Li F, Ahn RS, Naini BV, Groysberg VM, Zheng Y, Aziz A, Nevarez-Mejia J, Zarrinpar A, Busuttil RW, Gjertson DW, Kupiec-Weglinski JW, Reed EF.

    Hepatology. 2020 May 19. doi: 10.1002/hep.31324. Online ahead of print.

    PMID: 32426849